On September 26, 2025, Nexalin Technology, Inc. announced that the United States Patent and Trademark Office issued U.S. Design Patent No. D1,092,758, titled "Transcranial Electro‑Stimulation Device," for its next‑generation HALO™ Clarity neuromodulation headset.
The design patent provides 15 years of protection for the HALO™ Clarity device, which delivers non‑invasive neuromodulation by stimulating deep brain structures associated with mental health and neurological conditions. The patent strengthens Nexalin’s intellectual‑property estate, supporting the company’s DIFS™ platform and ongoing clinical and regulatory initiatives.
With the patent in place, Nexalin can scale manufacturing and pursue broader clinical deployment of HALO™ Clarity while safeguarding its unique design against competitors, thereby reinforcing its strategic position in the emerging non‑invasive neurostimulation market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.